Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 466-471

  Rabban, Joseph T ^a   MacKey, Amber ^a   Powell, C Bethan ^a   Crawford, Beth ^b   Zaloudek, Charles J ^a   Chen, Lee May ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BRCA; Fallopian tube; Intraoperative evaluation; Occult carcinoma; Risk reducing salpingo oophorectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; FEMALE; FROZEN SECTION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSCOPY; OVARY CARCINOMA; OVARY CYST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCING SALPINGO OOPHORECTOMY; SALPINGOOOPHORECTOMY; TISSUE SECTION; UTERINE TUBE CARCINOMA; UTERINE TUBE TUMOR;

ADULT; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; OVARIECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79957504220     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.01.031     Document Type: Article

References (38)

1. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2 2006 Jul 12 185 192
2. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2 2009 Jan 21 80 87
3. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2 2006 Feb 230 236 (Pubitemid 43740193)
4. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 10 2001 Oct 1283 1289 (Pubitemid 32917122)
5. N.D. Kauff, J.M. Satagopan, M.E. Robson, L. Scheuer, M. Hensley, and C.A. Hudis Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 2002 May 23 1609 1615 (Pubitemid 34755668)
6. K.H. Lu, J.E. Garber, D.W. Cramer, W.R. Welch, J. Niloff, and D. Schrag Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J Clin Oncol 18 14 2000 Jul 2728 2732 (Pubitemid 30463555)
7. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 1 2005 Jan 1 127 132 (Pubitemid 41702631)
8. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, V.L. Van't, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 21 2002 May 23 1616 1622 (Pubitemid 34755669)
9. Y. Lee, F. Medeiros, D. Kindelberger, M.J. Callahan, M.G. Muto, and C.P. Crum Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer Adv Anat Pathol 13 1 2006 Jan 1 7 (Pubitemid 44357143)
10. J.T. Rabban, E. Krasik, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol Am J Surg Pathol 33 12 2009 Dec 1878 1885
11. P. Baker, and E. Oliva A practical approach to intraoperative consultation in gynecological pathology Int J Gynecol Pathol 27 3 2008 Jul 353 365
12. D. Coffey, A.L. Kaplan, and I. Ramzy Intraoperative consultation in gynecologic pathology Arch Pathol Lab Med 129 12 2005 Dec 1544 1557 (Pubitemid 41772628)
13. E.B. Desciak, and M.E. Maloney Artifacts in frozen section preparation Dermatol Surg 26 5 2000 May 500 504 (Pubitemid 30305336)
14. E.A. Saglam, A. Usubutun, A. Ayhan, and T. Kucukali Mistakes prevent mistakes: experience from intraoperative consultation with frozen section Eur J Obstet Gynecol Reprod Biol 125 2 2006 Apr 1 266 268
15. C.J. Stewart, B.A. Brennan, I.G. Hammond, Y.C. Leung, and A.J. McCartney Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases Int J Gynecol Pathol 25 3 2006 Jul 216 222 (Pubitemid 44610033)
16. A. Usubutun, G. Altinok, and T. Kucukali The value of intraoperative consultation (frozen section) in the diagnosis of ovarian neoplasms Acta Obstet Gynecol Scand 77 10 1998 Nov 1013 1016 (Pubitemid 29043929)
17. K.G. Wang, T.C. Chen, T.Y. Wang, Y.C. Yang, and T.H. Su Accuracy of frozen section diagnosis in gynecology Gynecol Oncol 70 1 1998 Jul 105 110
18. N.D. Kauff, and R.R. Barakat Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2 J Clin Oncol 25 20 2007 Jul 10 2921 2927 (Pubitemid 47123156)
19. NCCN Practice Guidelines in Oncology v.1 Hereditary breast and/or ovarian cancer 2010 www nccn org 2010 March 8Available from: URL: www.nccn.org
20. Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy Gynecol Oncol 98 2 2005 Aug 179 181
21. ACOG ACOG practice bulletin no. 89. Elective and risk-reducing salpingo-oophorectomy Obstet Gynecol 111 1 2008 Jan 231 241
22. ACOG ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome Obstet Gynecol 113 4 2009 Apr 957 966
23. T.A. Longacre, E. Oliva, and R.A. Soslow Recommendations for the reporting of fallopian tube neoplasms Hum Pathol 38 8 2007 Aug 1160 1163
24. I. Alvarado-Cabrero, R.H. Young, E.C. Vamvakas, and R.E. Scully Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors Gynecol Oncol 72 3 1999 Mar 367 379 (Pubitemid 29118195)
25. E. Jarboe, A. Folkins, M.R. Nucci, D. Kindelberger, R. Drapkin, and A. Miron Serous carcinogenesis in the fallopian tube: a descriptive classification Int J Gynecol Pathol 27 1 2008 Jan 1 9 (Pubitemid 351627965)
26. J.T. Rabban, B. Crawford, L.M. Chen, C.B. Powell, and C.J. Zaloudek Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women with BRCA mutations Am J Surg Pathol 33 1 2009 Jan 111 119
27. J.T. Rabban, M. Barnes, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma Am J Surg Pathol 33 8 2009 Aug 1125 1136
28. M. Mehrad, G. Ning, E.Y. Chen, K.K. Mehra, and C.P. Crum A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube Adv Anat Pathol 17 5 2010 Sep 293 302
29. J. Qiu, S. Kulkarni, R. Chandrasekhar, M. Rees, K. Hyde, and G. Wilding Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones Am J Clin Pathol 134 5 2010 Nov 813 819
30. H. Yaziji, C.R. Taylor, N.S. Goldstein, D.J. Dabbs, E.H. Hammond, and B. Hewlett Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry Appl Immunohistochem Mol Morphol 16 6 2008 Dec 513 520
31. T. Khoury, S. Sait, H. Hwang, R. Chandrasekhar, G. Wilding, and D. Tan Delay to formalin fixation effect on breast biomarkers Mod Pathol 22 11 2009 Nov 1457 1467
32. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 1 2006 Jan 58 64 (Pubitemid 41815050)
33. S.N. Agoff, J.E. Mendelin, V.S. Grieco, and R.L. Garcia Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up Am J Surg Pathol 26 2 2002 Feb 171 178 (Pubitemid 34127496)
34. P.J. Paley, E.M. Swisher, R.L. Garcia, S.N. Agoff, B.E. Greer, and K.L. Peters Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecol Oncol 80 2 2001 Feb 176 180 (Pubitemid 32158455)
35. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 25 2007 Sep 1 3985 3990 (Pubitemid 47477278)
36. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 1 2002 Oct 52 56 (Pubitemid 36027101)
37. M.L. Carcangiu, B. Peissel, B. Pasini, G. Spatti, P. Radice, and S. Manoukian Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature Am J Surg Pathol 30 10 2006 Oct 1222 1230 (Pubitemid 44454699)
38. P. Morice, P. Pautier, S. Delaloge, A. Spatz, and A. Chompret Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implications Eur J Obstet Gynecol Reprod Biol 113 2 2004 Apr 15 251 254 (Pubitemid 38456786)